Cargando…

Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2

BACKGROUND: Recent studies have shown that production of cortisol not only takes place in several non-adrenal peripheral tissues such as epithelial cells but, also, the local inter-conversion between cortisone and cortisol is regulated by the 11β-hydroxysteroid dehydrogenases (11β-HSDs). However, li...

Descripción completa

Detalles Bibliográficos
Autores principales: Cirillo, Nicola, Morgan, David J, Pedicillo, Maria Carmela, Celentano, Antonio, Lo Muzio, Lorenzo, McCullough, Michael J, Prime, Stephen S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625663/
https://www.ncbi.nlm.nih.gov/pubmed/28797028
http://dx.doi.org/10.1038/bjc.2017.243
_version_ 1783268425141846016
author Cirillo, Nicola
Morgan, David J
Pedicillo, Maria Carmela
Celentano, Antonio
Lo Muzio, Lorenzo
McCullough, Michael J
Prime, Stephen S
author_facet Cirillo, Nicola
Morgan, David J
Pedicillo, Maria Carmela
Celentano, Antonio
Lo Muzio, Lorenzo
McCullough, Michael J
Prime, Stephen S
author_sort Cirillo, Nicola
collection PubMed
description BACKGROUND: Recent studies have shown that production of cortisol not only takes place in several non-adrenal peripheral tissues such as epithelial cells but, also, the local inter-conversion between cortisone and cortisol is regulated by the 11β-hydroxysteroid dehydrogenases (11β-HSDs). However, little is known about the activity of this non-adrenal glucocorticoid system in cancers. METHODS: The presence of a functioning glucocorticoid system was assessed in human skin squamous cell carcinoma (SCC) and melanoma and further, in 16 epithelial cell lines from 8 different tissue types using ELISA, western blotting and immunofluorescence. 11β-HSD2 was inhibited both pharmacologically and by siRNA technology. Naïve CD8(+) T cells were used to test the paracrine effects of cancer-derived cortisol on the immune system in vitro. Functional assays included cell–cell adhesion and cohesion in two- and three-dimensional models. Immunohistochemical data of 11β-HSD expression were generated using tissue microarrays of 40 cases of human SCCs as well as a database featuring 315 cancer cases from 15 different tissues. RESULTS: We show that cortisol production is a common feature of malignant cells and has paracrine functions. Cortisol production correlated with the magnitude of glucocorticoid receptor (GR)-dependent inhibition of tumour-specific CD8(+) T cells in vitro. 11β-HSDs were detectable in human skin SCCs and melanoma. Analyses of publicly available protein expression data of 11β-HSDs demonstrated that 11β-HSD1 and -HSD2 were dysregulated in the majority (73%) of malignancies. Pharmacological manipulation of 11β-HSD2 activity by 18β-glycyrrhetinic acid (GA) and silencing by specific siRNAs modulated the bioavailability of cortisol. Cortisol also acted in an autocrine manner and promoted cell invasion in vitro and cell–cell adhesion and cohesion in two- and three-dimensional models. Immunohistochemical analyses using tissue microarrays showed that expression of 11β-HSD2 was significantly reduced in human SCCs of the skin. CONCLUSIONS: The results demonstrate evidence of a cancer-associated glucocorticoid system and show for the first time, the functional significance of cancer-derived cortisol in tumour progression.
format Online
Article
Text
id pubmed-5625663
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56256632018-09-26 Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2 Cirillo, Nicola Morgan, David J Pedicillo, Maria Carmela Celentano, Antonio Lo Muzio, Lorenzo McCullough, Michael J Prime, Stephen S Br J Cancer Molecular Diagnostics BACKGROUND: Recent studies have shown that production of cortisol not only takes place in several non-adrenal peripheral tissues such as epithelial cells but, also, the local inter-conversion between cortisone and cortisol is regulated by the 11β-hydroxysteroid dehydrogenases (11β-HSDs). However, little is known about the activity of this non-adrenal glucocorticoid system in cancers. METHODS: The presence of a functioning glucocorticoid system was assessed in human skin squamous cell carcinoma (SCC) and melanoma and further, in 16 epithelial cell lines from 8 different tissue types using ELISA, western blotting and immunofluorescence. 11β-HSD2 was inhibited both pharmacologically and by siRNA technology. Naïve CD8(+) T cells were used to test the paracrine effects of cancer-derived cortisol on the immune system in vitro. Functional assays included cell–cell adhesion and cohesion in two- and three-dimensional models. Immunohistochemical data of 11β-HSD expression were generated using tissue microarrays of 40 cases of human SCCs as well as a database featuring 315 cancer cases from 15 different tissues. RESULTS: We show that cortisol production is a common feature of malignant cells and has paracrine functions. Cortisol production correlated with the magnitude of glucocorticoid receptor (GR)-dependent inhibition of tumour-specific CD8(+) T cells in vitro. 11β-HSDs were detectable in human skin SCCs and melanoma. Analyses of publicly available protein expression data of 11β-HSDs demonstrated that 11β-HSD1 and -HSD2 were dysregulated in the majority (73%) of malignancies. Pharmacological manipulation of 11β-HSD2 activity by 18β-glycyrrhetinic acid (GA) and silencing by specific siRNAs modulated the bioavailability of cortisol. Cortisol also acted in an autocrine manner and promoted cell invasion in vitro and cell–cell adhesion and cohesion in two- and three-dimensional models. Immunohistochemical analyses using tissue microarrays showed that expression of 11β-HSD2 was significantly reduced in human SCCs of the skin. CONCLUSIONS: The results demonstrate evidence of a cancer-associated glucocorticoid system and show for the first time, the functional significance of cancer-derived cortisol in tumour progression. Nature Publishing Group 2017-09-26 2017-08-10 /pmc/articles/PMC5625663/ /pubmed/28797028 http://dx.doi.org/10.1038/bjc.2017.243 Text en Copyright © 2017 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Molecular Diagnostics
Cirillo, Nicola
Morgan, David J
Pedicillo, Maria Carmela
Celentano, Antonio
Lo Muzio, Lorenzo
McCullough, Michael J
Prime, Stephen S
Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2
title Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2
title_full Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2
title_fullStr Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2
title_full_unstemmed Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2
title_short Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2
title_sort characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2
topic Molecular Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625663/
https://www.ncbi.nlm.nih.gov/pubmed/28797028
http://dx.doi.org/10.1038/bjc.2017.243
work_keys_str_mv AT cirillonicola characterisationofthecancerassociatedglucocorticoidsystemkeyroleof11bhydroxysteroiddehydrogenasetype2
AT morgandavidj characterisationofthecancerassociatedglucocorticoidsystemkeyroleof11bhydroxysteroiddehydrogenasetype2
AT pedicillomariacarmela characterisationofthecancerassociatedglucocorticoidsystemkeyroleof11bhydroxysteroiddehydrogenasetype2
AT celentanoantonio characterisationofthecancerassociatedglucocorticoidsystemkeyroleof11bhydroxysteroiddehydrogenasetype2
AT lomuziolorenzo characterisationofthecancerassociatedglucocorticoidsystemkeyroleof11bhydroxysteroiddehydrogenasetype2
AT mcculloughmichaelj characterisationofthecancerassociatedglucocorticoidsystemkeyroleof11bhydroxysteroiddehydrogenasetype2
AT primestephens characterisationofthecancerassociatedglucocorticoidsystemkeyroleof11bhydroxysteroiddehydrogenasetype2